Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders

Nobili, Flavio; Festari, Cristina; Altomare, Daniele; Agosta, Federica; Orini, Stefania; Van Laere, Koen; Arbizu, Javier; Bouwman, Femke; Drzezga, Alexander; Nestor, Peter; Walker, Zuzana; Boccardi, Marina

doi:10.1007/s00259-018-4030-3

Scientific article

English

Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders

ContributorsNobili, Flavio; Festari, Cristina; Altomare, Daniele; Agosta, Federica; Orini, Stefania; Van Laere, Koen; Arbizu, Javier; Bouwman, Femke; Drzezga, Alexander; Nestor, Peter; Walker, Zuzana; Boccardi, Marina

Published inEuropean Journal of Nuclear Medicine and Molecular Imaging, vol. 45, no. 9, p. 1557-1566

Publication date2018

Abstract

To review literature until November 2015 and reach a consensus on whether automatic semi-quantification of brain FDG-PET is useful in the clinical setting for neurodegenerative disorders.

Keywords

Dementia/diagnostic imaging
Diagnosis, Differential
Fluorodeoxyglucose F18
Humans
Neurodegenerative Diseases/diagnostic imaging
Positron-Emission Tomography
Sensitivity and Specificity

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de réadaptation et gériatrie

Research groups

Troubles de mémoire et maladie d'Alzeimer (935)

Citation (ISO format)

NOBILI, Flavio et al. Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders. In: European Journal of Nuclear Medicine and Molecular Imaging, 2018, vol. 45, n° 9, p. 1557–1566. doi: 10.1007/s00259-018-4030-3

Article (Published version)

Identifiers

PID : unige:114049
DOI : 10.1007/s00259-018-4030-3
PMID : 29721650

ISSN of the journal1619-7070

304views

0downloads

Creation01/04/2019 4:16:00 PM

First validation01/04/2019 4:16:00 PM

Update time03/15/2023 3:43:04 PM

Status update03/15/2023 3:43:03 PM

Last indexation10/31/2024 12:38:43 PM

Archive ouverte UNIGE

Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders

To review literature until November 2015 and reach a consensus on whether automatic semi-quantification of brain FDG-PET is useful in the clinical setting for neurodegenerative disorders.

Technical informations